 |
 |

Muramyl Dipeptide Enhances Survival From Experimental Peritonitis
Gregory L. Brown, MD;
Hugh Foshee;
James Pietsch;
Hiram C. Polk, Jr, MD
Arch Surg. 1986;121(1):47-49.
Abstract
Muramyl dipeptide is a nonspecific immunostimulant derived from Freund's complete adjuvant. We determined the effect of muramyl dipeptide on two separate animal models for peritonitis. We found that administration of muramyl dipeptide to rats undergoing cecal ligation and puncture significantly reduced mortality. Similarly, mice that underwent cecal ligation alone with muramyl dipeptide administration also had a statistically significant reduction in mortality compared with untreated controls.
(Arch Surg 1986;121:47-49)
Author Affiliations
From the Price Institute of Surgical Research (Dr Brown and Messrs Foshee and Pietsch) and the Department of Surgery (Dr Polk), University of Louisville School of Medicine.
Footnotes
Accepted for publication Aug 9, 1985.
Read before the Fifth Annual Meeting of the Surgical Infection Society, New Orleans, April 29, 1985.
Reprint requests to Department of Surgery, Ambulatory Care Building, University of Louisville, Louisville, KY 40292 (Dr Polk).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Natural History of Murine Intra-abdominal Abscess Formation
Cheadle et al.
Arch Surg 1988;123:1342-1346.
ABSTRACT
Effects of Muramyl Dipeptide and Core Body Temperature on Peritoneal Bacterial Clearance
Stellato et al.
Arch Surg 1988;123:465-469.
ABSTRACT
|